首页> 美国卫生研究院文献>other >Syndecan-1 Limits the Progression of Liver Injury and Promotes Liver Repair in Acetaminophen-Induced Liver Injury in Mice
【2h】

Syndecan-1 Limits the Progression of Liver Injury and Promotes Liver Repair in Acetaminophen-Induced Liver Injury in Mice

机译:Syndecan-1限制了对乙酰氨基酚引起的小鼠肝损伤的进展并促进了肝修复。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Accidental or intentional misuse of acetaminophen (APAP) is the leading cause of acute liver failure in the Western world. Although mechanisms that trigger APAP-induced liver injury (AILI) are well known, those that halt the progression of APAP liver disease and facilitate liver recovery are less understood. Heparan sulfate proteoglycans (HSPGs) bind to and regulate various tissue injury factors through their heparan sulfate (HS) chains, but the importance of HSPGs in liver injury in vivo remains unknown. Here, we examined the role of syndecan-1, the major cell-surface HSPG of hepatocytes, in AILI. Ablation of syndecan-1 in mice led to unopposed progression of liver injury upon APAP overdose. However, direct APAP hepatoxicity and liver injury at early times post-APAP overdose were unaffected by syndecan-1, suggesting that syndecan-1 influences later mechanisms that lead to liver repair. The exuberant liver injury phenotypes in syndecan-1 null (Sdc1–/–) mice were traced to a deficiency in protein kinase B (Akt) activation in hepatocytes, which led to a delayed increase in glycogen synthase kinase-3β (GSK-3β)-mediated hepatocyte apoptosis. Inhibition of Akt worsened, whereas inhibition of GSK-3β and caspases protected mice from AILI. Moreover, administration of purified syndecan-1, HS, or engineered heparan compounds containing 2-O-sulfate groups rescued Sdc1–/– mice from AILI by potentiating Akt signaling and inhibiting GSK-3β-mediated apoptosis in hepatocytes. In addition, HS showed a significantly prolonged therapeutic efficacy as compared to N-acetylcysteine.Conclusion:These results demonstrate that 2-O-sulfated domains in syndecan-1 HS halt disease progression and promote liver repair by enhancing hepatocyte survival in AILI. We propose that syndecan-1 is a critical endogenous factor that controls the balance between prosurvival signaling and apoptosis in hepatocytes in APAP liver disease.
机译:意外或故意滥用对乙酰氨基酚(APAP)是西方世界急性肝衰竭的主要原因。尽管触发APAP引起的肝损伤(AILI)的机制是众所周知的,但阻止APAP肝病进展并促进肝恢复的机制却鲜为人知。硫酸乙酰肝素蛋白聚糖(HSPG)通过其硫酸乙酰肝素(HS)链结合并调节各种组织损伤因子,但是HSPG在体内肝损伤中的重要性仍然未知。在这里,我们检查了AILI中肝细胞主要细胞表面HSPG syndecan-1的作用。过量使用APAP会导致小鼠syndecan-1的消融导致肝损伤的无进展发展。但是,过量使用APAP后,早期的直接APAP肝毒性和肝损伤不受syndecan-1的影响,这表明syndecan-1影响后来导致肝修复的机制。 syndecan-1 null(Sdc1 – / – )小鼠中旺盛的肝损伤表型可归因于肝细胞中蛋白激酶B(Akt)激活的缺乏,从而导致糖原合酶激酶的延迟增加-3β(GSK-3β)介导的肝细胞凋亡。对Akt的抑制作用加剧,而对GSK-3β和半胱氨酸蛋白酶的抑制作用使小鼠免受AILI侵害。此外,通过纯化的含有2-O-硫酸基团的syndecan-1,HS或工程化乙酰肝素化合物的给药,可通过增强Akt信号传导并抑制GSK-3β介导的细胞凋亡从AILI中拯救Sdc1 – / – 小鼠。肝细胞。此外,与N-乙酰半胱氨酸相比,HS的治疗效果显着延长。结论:这些结果表明syndecan-1 HS中的2-O-硫酸化结构域可阻止疾病进展并通过增强AILI中的肝细胞存活来促进肝脏修复。我们提出,syndecan-1是一个关键的内源性因素,它控制着APAP肝病的生存信号和肝细胞凋亡之间的平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号